To include your compound in the COVID-19 Resource Center, submit it here.

Kintor IPO latest sign of Hong Kong’s maturing biotech chapter

On a turbulent day for the Hong Kong stock exchange, shares of oncology company Kintor gained HK$1.35 to HK$21.50 in their first day of trading

Read the full 255 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE